MedPath

Effect of MMF on interstitial lung disease associated with collagen vascular diseases

Not Applicable
Completed
Conditions
interstitial lung disease associated with collagen vascular diseases
Registration Number
JPRN-jRCT1091220173
Lead Sponsor
Toshinori Takada
Brief Summary

This study had various limitations. We found, however, one case in which interstitial lung disease improved after the addition of MMF to the previous treatment. The results suggest that MMF might be one of the most effective treatment options for interstitial lung diseases associated with collagen vascular diseases.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

interstitial lung disease associated with collagen vascular diseases resistant to conventional therapy

Exclusion Criteria

physician's decision

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
safety
Secondary Outcome Measures
NameTimeMethod
efficacy
© Copyright 2025. All Rights Reserved by MedPath